Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma

PURPOSE: The multitargeted tyrosine kinase inhibitor sorafenib is used for the treatment of advanced-stage renal cell carcinoma. However, the safety and efficacy of this agent have yet to be evaluated in the preoperative period, where there may be potential advantages including tumor downstaging. Th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Cowey, C. Lance, Amin, Chirag, Pruthi, Raj S., Wallen, Eric M., Nielsen, Matthew E., Grigson, Gayle, Watkins, Cathy, Nance, Keith V., Crane, Jeffrey, Jalkut, Mark, Moore, Dominic T., Kim, William Y., Godley, Paul A., Whang, Young E., Fielding, Julia R., Rathmell, W. Kimryn
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4525128/
https://ncbi.nlm.nih.gov/pubmed/20159822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.24.7759
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados